Application Nr Approved Date Route Status External Links
NDA020955 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ferrlecit Is Indicated For The Treatment Of Iron Deficiency Anemia In Adult Patients And In Pediatric Patients Age 6 Years And Older With Chronic Kidney Disease Receiving Hemodialysis Who Are Receiving Supplemental Epoetin Therapy. Ferrlecit Is An Iron Replacement Product For Treatment Of Iron Deficiency Anemia In Adult Patients And In Pediatric Patients Age 6 Years And Older With Chronic Kidney Disease Receiving Hemodialysis Who Are Receiving Supplemental Epoetin Therapy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sodium Ferric Gluconate Complex

Comments